115 results
8-K
EX-99.1
NAOV
NanoVibronix Inc
16 May 24
NanoVibronix Issues Letter to Stockholders
4:05pm
to deliver impressive results with high patient satisfaction, with no demonstrated adverse events. We are also investing in sales improvement and long-term opportunities
8-K
EX-99.1
NAOV
NanoVibronix Inc
9 Apr 24
NanoVibronix Issues Letter to Stockholders
4:05pm
products continue to deliver impressive results with high patient satisfaction, with no adverse events. We are investing in sales improvement and long … -term opportunities with all of our products.
Q4 Financial Results
We recorded revenues of approximately $1.2 million for the quarter ended December 31
8-K
EX-10.7
6kgoh
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.9
hzb eb0q1gbe6x
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.8
0bfw6g2o4o4u5wom0a
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.4
fx7g3a km
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.3
23vfehmp
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.5
g9dr1k899 b021tcvxb
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.1
fmgmwovqc5tdqek531
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.2
xwn3ag4yjzfvvb8 4q
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.6
v27e4zzd m7
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-99.1
dgi5xzu
6 Sep 23
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
8:30am
8-K
EX-99.1
m2e 5lsk2
30 Aug 23
NanoVibronix Cites Positive Results from Independent Testing of UroShield
8:30am